Latest Cash Flow News

InFocus Group Holdings has launched Codexa, a proprietary sweepstakes casino platform targeting the US market, and secured an expanded contract for its Prodigy9 subsidiary in Thailand, while navigating cash flow pressures amid ongoing R&D investment.

Neuren Pharmaceuticals reported a solid A$30.4 million net profit in 2025, powered by a 15% rise in DAYBUE® royalties. The company is progressing its NNZ-2591 Phase 3 trial for Phelan-McDermid syndrome and has initiated a share buy-back amid perceived undervaluation.

Stakk Ltd (ASX: SKK) has delivered a striking 272% jump in gross receipts to $5.36 million in Q3 FY26, reversing prior cash outflows with a positive net cash flow of $2.25 million and closing the quarter with $17.34 million in cash.

Invex Therapeutics reported promising preclinical findings on Exenatide’s effects in a human Alzheimer's disease model, alongside a steady cash position and reduced operating outflows in Q3 FY26.

Energy Resources of Australia (ERA) advances rehabilitation at its Ranger site while awaiting a Federal Court decision on Rio Tinto’s compulsory acquisition bid. Seasonal conditions and higher rainfall have delayed critical Pit 3 capping trials, with financial reserves remaining strong despite no production activity.

Saferoads Holdings maintained steady sales in the March quarter with a positive operating cash flow and ongoing product upgrades, despite cost pressures from oil-based materials and uncertainty over future orders from On-site Rentals.

Investigator Silver has locked in a robust Definitive Feasibility Study for its Paris Silver Project, backed by a strategic A$55 million placement to fast-track early works and financing.

Vinyl Group lifted its Q3 cash receipts by 24% to $4 million despite seasonal softness and completed the $10.5 million acquisition of Val Morgan Digital, expanding its digital audience to rival major Australian media players. The company now targets an EBITDA positive run-rate in the first half of FY27 amid leadership changes and strategic realignment.

Hillgrove Resources (ASX:HGO) marked its first full year of underground copper production at Kanmantoo with 11,315 tonnes produced, returning to profitability and significantly boosting its Mineral Resources and Ore Reserves. The company is advancing growth projects and sustainability initiatives to underpin a production ramp-up in 2026.

Noxopharm signed a strategic MoU with Tezcat Biosciences, published major Sofra RNA research, and appointed Dr Olivier Laczka as CEO, while reporting positive safety data from its HERACLES trial and improving cash flow.

KGL Resources delivers a robust Baseline Economic Model for its Jervois Copper-Silver-Gold Project, highlighting a pre-tax NPV8 of A$1.226 billion and a 37% IRR, underpinning imminent project financing and construction plans.

De.mem Limited has extended its growth streak with record quarterly cash receipts of approximately $10.4 million, a 31% increase year-on-year, alongside positive operating cash flow of $504,000 for the March 2026 quarter.